M. E. Jung

发表

A Liquid Chromatography-Quadrupole-Time-of-Flight Mass Spectrometric Assay for the Quantification of Fabry Disease Biomarker Globotriaosylceramide (GB3) in Fabry Model Mouse

Jinwook Seo, Y. Shin, D. Jin, 2018, Pharmaceutics.

Novel macrocyclic C-aryl glucoside SGLT2 inhibitors as potential antidiabetic agents.

Min Ju Kim, Jinhwa Lee, Jun Sung Lee, 2011, Bioorganic & medicinal chemistry.

Novel C-aryl glucoside SGLT2 inhibitors as potential antidiabetic agents: Pyridazinylmethylphenyl glucoside congeners.

Min Ju Kim, J. Lee, Jinhwa Lee, 2010, Bioorganic & medicinal chemistry letters.

Novel C-aryl glucoside SGLT2 inhibitors as potential antidiabetic agents: 1,3,4-Thiadiazolylmethylphenyl glucoside congeners.

Jinhwa Lee, H. Seo, Junwon Lee, 2010, Bioorganic & medicinal chemistry.

Molecular Design and Characterization of a Novel, Vwf Independent Coagulation Factor VIII (LAFATE)

Kim Yong Jae, Seung-Hoon Lee, M. E. Jung, 2017 .

Methylsulfonylpyrazolyl oxadiazoles and thiadiazoles as potent, orally bioavailable cannabinoid-1 receptor antagonists for the treatment of obesity.

Min Ju Kim, Chong-Hwan Chang, Hyun-Ju Park, 2009, Future medicinal chemistry.

Oxadiazole-diarylpyrazole 4-carboxamides as cannabinoid CB1 receptor ligands.

Min Ju Kim, Jinhwa Lee, H. Seo, 2009, Bioorganic & medicinal chemistry letters.

Further optimization of novel pyrrole 3-carboxamides for targeting serotonin 5-HT(2A), 5-HT(2C), and the serotonin transporter as a potential antidepressant.

Min Ju Kim, A. Pae, Jinhwa Lee, 2010, Bioorganic & medicinal chemistry.

Synthesis and SAR of Thiazolylmethylphenyl Glucoside as Novel C-Aryl Glucoside SGLT2 Inhibitors.

Min Ju Kim, Jinhwa Lee, H. Seo, 2011, ACS medicinal chemistry letters.

Diarylimidazolyl oxadiazole and thiadiazole derivatives as cannabinoid CB1 receptor antagonists.

Jong Yup Kim, Jinhwa Lee, Kwangwook Ahn, 2009, Bioorganic & medicinal chemistry letters.

Biarylpyrazolyl oxadiazole as potent, selective, orally bioavailable cannabinoid-1 receptor antagonists for the treatment of obesity.

Chong-Hwan Chang, Hyun-Ju Park, H. Yun, 2008, Journal of medicinal chemistry.

5-HT2C receptor modulators: a patent survey

Jinhwa Lee, Junwon Lee, Jinhwa Lee, 2010, Expert opinion on therapeutic patents.

Design and synthesis of novel arylpiperazine derivatives containing the imidazole core targeting 5-HT(2A) receptor and 5-HT transporter.

Min Ju Kim, Jinhwa Lee, H. Seo, 2011, Journal of medicinal chemistry.

Synthesis and structure-activity relationship of 1,2,4-triazole-containing diarylpyrazolyl carboxamide as CB1 cannabinoid receptor-ligand.

Min Ju Kim, Jinhwa Lee, Kwangwook Ahn, 2010, Bioorganic & medicinal chemistry.

Discovery of 2-(4-((1H-1,2,4-triazol-1-yl)methyl)-5-(4-bromophenyl)-1-(2-chlorophenyl)-1H-pyrazol-3-yl)-5-tert-butyl-1,3,4-thiadiazole (GCC2680) as a potent, selective and orally efficacious cannabinoid-1 receptor antagonist.

Min Ju Kim, J. Lee, H. Seo, 2010, Bioorganic & medicinal chemistry.

Design, synthesis and biological evaluation of piperazine analogues as CB1 cannabinoid receptor ligands.

Jong Yup Kim, Jinhwa Lee, Kwangwook Ahn, 2008, Bioorganic & medicinal chemistry.

Tetrazole-biarylpyrazole derivatives as cannabinoid CB1 receptor antagonists.

Jinhwa Lee, Kwangwook Ahn, H. Seo, 2008, Bioorganic & medicinal chemistry letters.

Target‐mediated drug disposition modeling of an anti‐TFPI antibody (MG1113) in cynomolgus monkeys to predict human pharmacokinetics and pharmacodynamics

Myung Eun Jung, Eun-Young Kwak, Min ju Kim, 2021, Journal of thrombosis and haemostasis : JTH.

Arylpiperazine-containing pyrrole 3-carboxamide derivatives targeting serotonin 5-HT(2A), 5-HT(2C), and the serotonin transporter as a potential antidepressant.

Min Ju Kim, A. Pae, Jinhwa Lee, 2010, Bioorganic & medicinal chemistry letters.

Discovery of 2-(4-((1H-1,2,4-triazol-1-yl)methyl)-5-(4-bromophenyl)-1-(2-chlorophenyl)-1H-pyrazol-3-yl)-5-tert-butyl-1,3,4-thiadiazole (GCC2680) as a potent, selective and orally efficacious cannabinoid-1 receptor antagonist.

Min Ju Kim, J. Lee, H. Seo, 2010, Bioorganic & medicinal chemistry.

MG1113, a specific anti–tissue factor pathway inhibitor antibody, rebalances the coagulation system and promotes hemostasis in hemophilia

B. Oh, Dong-sik Kim, Myung Eun Jung, 2020, Research and practice in thrombosis and haemostasis.